Cargando…
The response of cerebral metastases in small cell lung cancer to systemic chemotherapy.
Although small cell lung cancer (SCLC) is very chemosensitive, cerebral metastases are treated with radiotherapy in the belief that they are protected from chemotherapy by the blood-brain barrier (BBB). The validity of this assumption has not been tested in clinical practice. In a randomised trial o...
Autores principales: | Twelves, C. J., Souhami, R. L., Harper, P. G., Ash, C. M., Spiro, S. G., Earl, H. M., Tobias, J. S., Quinn, H., Geddes, D. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971312/ https://www.ncbi.nlm.nih.gov/pubmed/2153393 |
Ejemplares similares
-
Patients at risk of chemotherapy-associated toxicity in small cell lung cancer.
por: Morittu, L., et al.
Publicado: (1989) -
Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial.
por: Spiro, S. G., et al.
Publicado: (1989) -
Spinal cord compression in small cell lung cancer: a retrospective study of 610 patients.
por: Goldman, J. M., et al.
Publicado: (1989) -
A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial.
por: Earl, H. M., et al.
Publicado: (1991) -
A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial.
por: James, L. E., et al.
Publicado: (1996)